Stephen S. Lam
Sar, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Mortality differences in coronary patients with breast cancer treated with trimetazidine dihydrochloride: potential therapeutic implications.
Journal: Cardio-oncology (London, England)
Published: March 31, 2025
Treatment with trimetazidine dihydrochloride and lung cancer survival: Implications on metabolic re-programming.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 30, 2024
Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia.
Journal: EMBO molecular medicine
Published: August 09, 2020
Redefining prognostication of de novo cytogenetically normal acute myeloid leukemia in young adults.
Redefining prognostication of de novo cytogenetically normal acute myeloid leukemia in young adults.
Journal: Blood cancer journal
Published: August 01, 2020
Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia.
Journal: EMBO molecular medicine
Published: May 15, 2019
Asia Pacific Society of Human Genetics (APSHG) from conception to 2019: 13 years of collaboration to tackle congenital malformation and genetic disorders in Asia.
Journal: American journal of medical genetics. Part C, Seminars in medical genetics
Published: March 31, 2019
Under-recognition of 22q11.2 deletion in adult Chinese patients with conotruncal anomalies: implications in transitional care.
Journal: European journal of medical genetics
Published: October 21, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026